Ticker: UNCY

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) - quick read on what's happening inside the company and the income statement (figures are presented as in the 10‑Q; dollar amounts shown in the filing are in thousands). - Key balance sheet & capital facts: Cash and cash equivalents: $22,327 (June 30, ...

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) has recently released its quarterly report for the period ending March 31, 2025. Below is a summary of key financial aspects and company developments for the period. Positive Aspects: Net Income: For Q1 2025, Unicycive reported a net income of $570,000...